Clinicopathologic Characteristics, Treatment Outcomes of Pediatric Mycosis Fungoides in Turkey: A National Multicenter Retrospective Cohort
Authors:
- Dilek BayramgürlerDBDilek Bayramgürler
- Dilek SeçkinDSDilek Seçkin
- Ayşe Deniz YüceltenAYAyşe Deniz Yücelten
- Esin DiremsizoğluEDEsin Diremsizoğlu
- Esra AdışenEAEsra Adışen
- Bengü Nisa AkayBABengü Nisa Akay
- Salih Levent ÇınarSÇSalih Levent Çınar
- Pelin KartalPKPelin Kartal
- Aslı AksuAAAslı Aksu
- Burhan EnginBEBurhan Engin
- Arzu FerhatosmanoğluAFArzu Ferhatosmanoğlu
- Mehmet MelikoğluMMMehmet Melikoğlu
- 2 September 2026
- journal article
- research article
- Published by Wiley in Pediatric Dermatology
Abstract
Background and Objectives: This study aimed to characterize the clinical spectrum, diagnostic delay, treatment patterns, and outcomes of pediatric mycosis fungoides (MF) and to identify predictors of early response. Methods: This national multicenter retrospective study included patients diagnosed with histopathologically confirmed MF before 18 years of age. Demographic, clinical, histopathologic, immunophenotypic, staging, treatment, and follow‐up data were collected. Early response at 3–6 months (partial/complete response) was analyzed using logistic regression. Results: A total of 133 patients were included; 60.9% (81/133) were male. Median age at diagnosis was 13 years (IQR, 9–15) and median diagnostic delay was 18 months (IQR, 8–48). Classic morphology was recorded in 78.2% (104/133), and hypopigmented MF in 36.1% (48/133); overlapping morphologies were documented in 42.1% (56/133). Stage IA disease was present in 59.4% (79/133). Phototherapy was used in 60.9% (81/133). Early response occurred in 91.0% (121/133). BSA < 10% was independently associated with higher odds of early response (aOR 8.42, 95% CI 1.71–41.54; p = 0.009), whereas older age at diagnosis predicted lower odds (aOR 0.81 per year, 95% CI 0.67–0.98; p = 0.029). Relapse occurred in 28.5% (37/130) within median follow‐up of 22 months (median time to relapse of 8 months); 67.6% (25/37) relapsed within 12 months. Conclusion: In this cohort, pediatric MF presented at an early stage. Despite favorable early responses, relapse occurred in nearly one third, often within the first year, supporting long‐term surveillance. Higher BSA involvement and older age at diagnosis were associated with reduced early response.Keywords
This publication has 23 references indexed in Scilit:
- ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part two: treatmentBritish Journal of Dermatology, 2025
- Mycosis Fungoides in Paediatric Patients: A Real‐Life Retrospective StudyJEADV Clinical Practice, 2025
- Approach to Mycosis Fungoides in children: Consensus-based recommendationsJournal of the American Academy of Dermatology, 2024
- Pediatric Mycosis Fungoides: Retrospective Analysis of a Series With CD8+ Profile and Female PredominanceJournal of Pediatric Hematology/Oncology, 2021
- Mycosis Fungoides in Children and AdolescentsJAMA Dermatology, 2021
- Micosis fungoide en niños y adolescentes: descripción de una serie de 23 casosActas Dermo-Sifiliograficas, 2020
- Cutaneous T-cell LymphomaClinics In Laboratory Medicine, 2017
- Micosis fungoide. Experiencia en un hospital pediátricoActas Dermo-Sifiliograficas, 2017
- Juvenile mycosis fungoides: Cutaneous T-cell lymphoma with frequent follicular involvementJournal of the American Academy of Dermatology, 2014
- Outcome in 34 patients with juvenile‐onset mycosis fungoidesCancer, 2003